Imbed Biosciences
Imbed Biosciences is a leader in the design, development, and manufacture of advanced medical devices for soft tissues, burns, and ulcers. Their mission is to create innovative products that combine a synthetic, biocompatible matrix with antimicrobial benefits and moisture management to improve wound healing outcomes. They focus on high-risk surgical wounds, burns, and ulcers, providing solutions that are fully synthetic, antimicrobial, and tailored to complex wound needs.
Industries
Nr. of Employees
small (1-50)
Imbed Biosciences
Patents
Products
Microlyte SAM (synthetic skin substitute)
Antimicrobial synthetic skin substitute composed of biocompatible polymers with low levels of metallic/ionic silver for outpatient wound management (partial and full thickness pressure ulcers, venous stasis, diabetic ulcers).
PelashieldAM (burn wound matrix)
Fully synthetic, hydrophilic antimicrobial matrix formulated for complex burn wound management, designed to conform to wound beds and manage moisture.
Surgaflex (surgical wound matrix)
Ultra‑thin, low‑profile synthetic antimicrobial polymer matrix intended for acute and surgical wound management and integration with the wound bed.
Microlyte SAM (synthetic skin substitute)
Antimicrobial synthetic skin substitute composed of biocompatible polymers with low levels of metallic/ionic silver for outpatient wound management (partial and full thickness pressure ulcers, venous stasis, diabetic ulcers).
PelashieldAM (burn wound matrix)
Fully synthetic, hydrophilic antimicrobial matrix formulated for complex burn wound management, designed to conform to wound beds and manage moisture.
Surgaflex (surgical wound matrix)
Ultra‑thin, low‑profile synthetic antimicrobial polymer matrix intended for acute and surgical wound management and integration with the wound bed.
Services
On-site or remote demonstrations and clinical education for healthcare professionals on product application and use.
Information and processes to support independent distributorships and representation of products in clinical accounts.
Request-driven program allowing licensed U.S. healthcare providers to request product samples for evaluation in clinical practice under applicable compliance guidelines.
On-site or remote demonstrations and clinical education for healthcare professionals on product application and use.
Information and processes to support independent distributorships and representation of products in clinical accounts.
Request-driven program allowing licensed U.S. healthcare providers to request product samples for evaluation in clinical practice under applicable compliance guidelines.
Expertise Areas
- Wound care therapeutics and synthetic skin substitutes
- Biomaterials and polymer formulation
- Antimicrobial medical device integration
- Clinical evaluation and outcomes research
Key Technologies
- Fully synthetic three-dimensional polymer matrices
- Hydrophilic polyvinyl alcohol (PVA) formulations
- Metallic/ionic silver antimicrobial integration
- Silver‑gallium antimicrobial combinations
News & Updates
Boswick Symposium | Boswick Burn and Wound Care Symposium in Maui, Hawaii, January 27 – February 1, 2024.
FDA IDE approval enables testing of Imbed’s Silver-Gallium, Ultra-Thin Matrix Technology in human clinical studies, a key step towards marketing approval.
First antimicrobial wound dressing with integrated lidocaine to manage painful wounds.
Awarded by Premier, Inc. through its Kiindo™ pediatric performance group and collaborative.
Boswick Symposium | Boswick Burn and Wound Care Symposium in Maui, Hawaii, January 27 – February 1, 2024.
FDA IDE approval enables testing of Imbed’s Silver-Gallium, Ultra-Thin Matrix Technology in human clinical studies, a key step towards marketing approval.
First antimicrobial wound dressing with integrated lidocaine to manage painful wounds.
Awarded by Premier, Inc. through its Kiindo™ pediatric performance group and collaborative.